Alector alector.com


Public list: Pharma Startups (6570) Google In Healthcare (60) Neuroscience Startups (947)

Alector is a neurology-focused startup that is focused on the discovery and development of immuno-modulatory therapies for Alzheimer's disease and other neurodegenerative disorders. The company is combining antibody technology and recent discoveries in neuro-immunology and human genetics to develop a platform of therapeutics that harness the immune system to fight dementia and neurodegeneration.

Alector is a neurology-focused startup that is focused on the discovery and development of immuno-modulatory therapies for Alzheimer's disease and other neurodegenerative disorders. The company is combining antibody technology and recent discoveries ...Show all

Company (IPO / Went public)

Phone: 415-231-5660

Fax:

151 Oyster Blvd
Suite 300
South San Francisco, 94080
California, United States

Latest News

See more competitors data Competitors
Total Funding Date of Last Funding
Alector $194.5M Feb 7, 2019

Web Traffic

Rank

Show (-10)

Engagement (PVPU)

Show (+1%)

Domain Authority Score
Show
Page Views Per Million (PVPM)
Show
Reach Per Million
Show

SEO Statistics

Domain Authority Score Show
Page Authority Score Show
No. External Links Show
No. Links Show

Web Traffic Statistics - Growth

Per Week Per Month Per 6 Months Per Year
Rank Login to see details
Page Views Per Million Login to see details
Page Views Per User Login to see details
Reach Per Million Login to see details

Related Alector Jobs

jobs by Indeed job
						search

Investors

Investor Investor Type Location Participating Rounds
See all 22 investors
There is no Competitors data available for this company. Please select another tab.

Patents

Title Application Date Patent Date Status
(Patent / Application)
Chimeric receptors and methods of use thereof Apr 26, 2017 Dec 29, 2020 Patent
Methods of screening for sortilin binding antagonists Apr 07, 2016 Dec 01, 2020 Patent
Anti-siglec-9 antibodies and methods of use thereof Oct 28, 2016 Oct 13, 2020 Patent
Anti-cd33 antibodies and methods of use thereof Aug 03, 2018 Jul 14, 2020 Patent
Anti-trem2 antibodies and methods of use thereof Aug 03, 2018 Jun 09, 2020 Patent
See all 34 patents